The c4c project aims to develop a Pan European Paediatric Clinical Trial Network. As part of the development of the c4c network we are creating a series of podcasts centred on the work of the network.

The how and why of COVID-19 vaccines for children

c4c has launched a new podcast series – each month we will be publishing a podcast on topical issues around c4c and paediatric research.

For our first podcast, we focus on Covid-19 vaccines for children and young people, with Dr Federico Martinòn-Torres providing insights about paediatric clinical trials.

Topics that are discussed during the podcast:

  • The reason behind the lack of paediatric clinical trials for COVID-19 vaccine
  • The necessity of having COVID-19 vaccines for children on the herd immunity as well as on the individual side
  • Social inequalities linked to school closures
  • The current challenges in paediatric clinical trials for COVID-19 vaccine

You can view the podcast directly on our podcast platform here.

cASPerCF: Proof of viability studies to test the c4c network

The c4c network is carrying out a selection of Proof of Viability (PoV) trials from both academia and industry to test its functionalities, and to build a more effective and sustainable network for the future. c4c have released two new podcasts about cASPerCF, one of the first non-industry PoV trials to test the network’s infrastructure. The cASPerCF trial aims to find the right dose of posaconazole to treat children and young people with Cystic Fibrosis and Aspergillus infection.

In the first podcast, we have Prof Adilia Warris providing an overview of the cASPerCF trial and how it is supported by the c4c network. Listen here.

In the second podcast, we have Jacob Bradbury providing a short overview on what Cystic Fibrosis is, how it affects children and what the aims of the trial are. Listen here.